Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-Up in Patients with Highly Active Disease: Post Hoc Analysis of Care-Ms I and Ii Patients in the Topaz Extension Study

AuthID
P-00S-HB9
19
Author(s)
Bass, AD
·
Berkovich, R
·
Eichau, S
·
Hobart, J
·
Hunter, SF
·
Limmroth, V
·
Pelletier, D
·
Pozzilli, C
·
Schippling, S
·
Traboulsee, A
·
Uitdehaag, BMJ
·
Van Wijmeersch, B
·
4
Group Author(s)
CARE-MS I Investigators; CARE-MS II Investigators; CAMMS03409 Investigators; TOPAZ Investigators
Document Type
Article
Year published
2020
Published
in CNS DRUGS, ISSN: 1172-7047
Volume: 34, Issue: 9, Pages: 973-988 (16)
Indexing
Publication Identifiers
Pubmed: 32710396
SCOPUS: 2-s2.0-85088573106
Wos: WOS:000552160400001
Source Identifiers
ISSN: 1172-7047
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.